Kenneth C. Frazier is the CEO of Merck & Co., Inc., and also is a member of Merck’s executive committee. Before joining Merck in 1992 as Vice President, General Counsel and Secretary of the Astra Merck Group, Mr. Frazier had spent 14 years in private practice at Drinker Biddle & Reath.
He was elected to the ALI in December 1996 and was elected to the Council in 2003.
As General Counsel at Merck, Mr. Frazier was credited with overseeing the company 's defense against Vioxx-related litigation. From 2007 to 2010, he served as Executive Vice President and President of the company 's Global Human Health unit. In 2010, he became Merck 's President and on January 1, 2011 he became its CEO and became Chairman on December 1, 2011.
EDUCATION: Penn State University, B.A.; Harvard Law School, J.D.